Index of reports
> Life Threatening Events (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Restasis (Cyclosporine Ophthalmic) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Restasis side effects in 63 year old female
Reported by a consumer/non-health professional from United States on 2012-02-15
Patient: 63 year old female, weighing 51.7 kg (113.8 pounds)
Reactions: Nasal Cavity Cancer, Squamous Cell Carcinoma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Restasis
Possible Restasis side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-24
Patient: female, weighing 81.6 kg (179.6 pounds)
Reactions: Dyspnoea, Chest Discomfort, Chest Pain, Cough
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Restasis
Dosage: 1 drop/eye 2x daily eye
Indication: Visual Impairment
Start date: 2011-03-12
End date: 2011-09-24
Restasis
Dosage: 1 drop/eye 2x daily eye
Indication: Vision Blurred
Start date: 2011-03-12
End date: 2011-09-24
Restasis
Dosage: 1 drop/eye 2x daily eye
Indication: Visual Impairment
Start date: 2011-09-19
End date: 2011-09-23
Restasis
Dosage: 1 drop/eye 2x daily eye
Indication: Vision Blurred
Start date: 2011-09-19
End date: 2011-09-23
|